Longduoduo Co Ltd Ordinary Shares LDDD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.50
- Day Range
- $4.99–5.00
- 52-Week Range
- $2.01–7.90
- Bid/Ask
- $3.25 / $5.66
- Market Cap
- $150.03 Mil
- Volume/Avg
- 202 / 180
Key Statistics
- Price/Earnings (Normalized)
- 130.31
- Price/Sales
- 15.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Longduoduo Co Ltd through its operating subsidiaries engaged in the business of providing preventive healthcare solutions. It provides a wide range of comprehensive preventive healthcare services including disease screening, healthcare treatments, healthcare products, and other services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. The company’s revenues are generated from its customers in the People’s Republic of China.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 65
- Website
- http://www.longduoduo.net
Comparables
Valuation
|
Metric
|
LDDD
|
ARCT
|
SMLR
|
|---|---|---|---|
Price/Earnings (Normalized) | 130.31 | — | 8.09 |
Price/Book Value | 339.24 | 2.59 | 2.14 |
Price/Sales | 15.39 | 4.52 | 3.03 |
Price/Cash Flow | 54.08 | — | 7.51 |
Price/Earnings
LDDD
ARCT
SMLR
Financial Strength
|
Metric
|
LDDD
|
ARCT
|
SMLR
|
|---|---|---|---|
Quick Ratio | 0.94 | 3.10 | 3.28 |
Current Ratio | 1.04 | 3.78 | 3.72 |
Interest Coverage | — | −3,734.00 | — |
Quick Ratio
LDDD
ARCT
SMLR
Profitability
|
Metric
|
LDDD
|
ARCT
|
SMLR
|
|---|---|---|---|
Return on Assets (Normalized) | 106.04% | −9.87% | 27.19% |
Return on Equity (Normalized) | — | −15.36% | 29.98% |
Return on Invested Capital (Normalized) | — | −18.47% | 26.53% |
Return on Assets
LDDD
ARCT
SMLR
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Vjywrywrc | Vdtxl | $229.5 Bil | |||
| Danaher Corp
DHR
| Nljtsxvjqt | Tjrhm | $195.4 Bil | |||
| Agilent Technologies Inc
A
| Cfkhlltm | Bhd | $41.5 Bil | |||
| IQVIA Holdings Inc
IQV
| Pfrpwtwk | Wynzq | $41.5 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Vnxckdqmt | Jqfn | $39.8 Bil | |||
| Mettler-Toledo International Inc
MTD
| Vkrjjbknsv | Qmjhzw | $31.1 Bil | |||
| Icon PLC
ICLR
| Fcvfdbzk | Fkvvld | $24.3 Bil | |||
| Illumina Inc
ILMN
| Tdwtszz | Tbrkqr | $21.7 Bil | |||
| Waters Corp
WAT
| Dfkbkmnkp | Flnyj | $21.0 Bil | |||
| Labcorp Holdings Inc
LH
| Dgctthkfjk | Djffwr | $18.1 Bil |
United States